TECH OFFER

Novel Compounds to Treat Dengue

TECHNOLOGY OVERVIEW

The present invention is directed to the novel compounds, formula (I) and methods for flavivirus infection, such as the serotype 2 dengue viral infection in human body. The invention is based upon the in vitro implying the monolayer of HepG2 cells that was derived from human hepatomas which closely resembles the true target tissue of liver that was involved in the pathogenesis of dengue fever.

Mega - Trends

Healthcare

Technology Readiness Level (TRL)

TRL 2

Patent Number

MY-169569-A

Get the technology fact sheet here:

Contact person for this offer:

ChM Dr. Lee Ching Shya, PhD (Dual), RTTP

Technology Transfer Manager

Email: leecs@um.edu.my

Tel: +603-7967-7351/ 013-2250151

MAKE AN ENQUIRY

press to zoom

press to zoom
1/1

MORE INFORMATION

You have a question to know about technologies or cooperations? 
Please Contact Us:

+603 - 7967 7351 / 013-2250151